5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Hester Biosciences Ltd.

•
hester.inBSE: 524669NSE: HESTERBIO
Market Cap₹ 1,948 Cr.
Current Price
High / Low₹ 2,684 / 1,239
Stock P/E14.3
Book Value₹ 535
Price to Book2.98
Dividend Yield0.48 %
ROCE16.2 %
ROE17.0 %
Face Value₹ 10

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2026 • Poultry Vaccines: 61.9% • Large Animal Health Products: 38.1%

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Latest quarter profit grew 459.3% YoY, showing strong momentum
  • Company has consistently been profitable over the last 5 years
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.65x)
  • Stock looks reasonably valued - P/E of 14.3 is below its historical median
  • Working capital cycle has improved - days down from 82 to 62
  • Company has a consistent dividend-paying track record

CONS

  • Receivables are growing faster than sales - a possible quality concern
  • Company has a low return on capital employed of 11.9%

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.Name
1.SUNPHARMA1842.0036.54441957.500.872901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9326.0084.64247576.000.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4975.0086.76189233.010.76566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1119.5024.74111670.550.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1365.0032.72110272.680.95785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1970.3597.37106460.420.10362.07123.942026.3129.1018.2031.50
7.DRREDDY1161.0030.0796906.380.69435.60-69.108099.80-5.2113.7510.63
8.AUROPHARMA1675.4525.9796401.690.241032.0325.229150.3517.4412.7620.54
9.LUPIN2096.0017.3495842.920.861416.9816.018276.8934.2828.8629.59
10.MANKIND2277.0046.0494050.370.04574.0929.124030.5912.8913.2426.30
11.GLENMARK2416.9037.9468210.880.10482.83927.884018.4831.3520.3520.03
12.HESTERBIO2289.9514.311948.030.4896.73459.2777.24-8.1616.2132.12
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
887067798284638284717710077
73575763656558636159606665
Operating Profit1413101618195192312183413
OPM %16.35%18.76%15.15%20.10%21.45%22.89%8.00%23.42%27.13%16.51%22.99%34.29%16.38%
1414128-72101-0-84
Interest382756-4622253
Depreciation5444444444467
Profit before Tax8559101112219151223102
Tax %29.18%52.21%45.96%36.95%31.96%31.90%15.82%90.16%15.10%18.21%34.48%36.76%4.87%
Net Profit0000781115171491797
7.894.754.737.528.809.8613.411.8220.3316.8510.9419.45113.71

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
123136178183214235266305311333326
8289110128146175216251250251249
Operating Profit4147685569605053618277
OPM %33.32%34.77%38.21%30.23%32.03%25.52%18.94%17.46%19.62%24.64%23.49%
03761141511417-73
Interest347774920131112
Depreciation710121313172117171922
Profit before Tax31365741505440324076152
Tax %26.34%36.14%28.43%24.98%30.75%26.20%30.18%33.76%27.15%24.20%13.43%
Net Profit23234131353928212957132
EPS26.7927.1247.8436.4440.7946.4132.9622.2032.3165.40—
Dividend Payout %19.15%33.20%22.51%19.25%24.71%21.64%25.56%27.02%21.66%16.82%—

COMPOUNDED SALES GROWTH

10 Years:
13%
5 Years:
9%
3 Years:
8%

COMPOUNDED PROFIT GROWTH

10 Years:
11%
5 Years:
10%
3 Years:
28%

STOCK PRICE CAGR

10 Years:
12%
5 Years:
-2%
3 Years:
9%
1 Year:
7%

RETURN ON EQUITY

10 Years:
16%
5 Years:
12%
3 Years:
11%
Last Year:
17%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

2026

Jul 14

₹ 1.10

Rs.11.0000 per share(110%)Final Dividend

2025

Aug 6

₹ 0.70

Rs.7.0000 per share(70%)Final Dividend

2024

Aug 22

₹ 0.60

Rs.6.0000 per share(60%)Dividend

2023

Sep 13

₹ 0.80

Rs.8.0000 per share(80%)Final Dividend

2022

Aug 11

₹ 1

Rs.10.0000 per share(100%)Dividend

2018

Aug 30

₹ 0.20

Rs.2/-(20%) First Interim Dividend

2018

Aug 2

₹ 0.60

Rs.6.0000 per share(60%)Final Dividend

2017

Nov 16

₹ 0.40

Interim Dividend

2017

Jul 20

₹ 0.23

Rs.2.3000 per share(23%)Final Dividend

2016

Nov 3

₹ 0.30

Interim Dividend

2016

Jul 21

₹ 0.11

Rs.1.1000 per share(11%)Final Dividend

2016

Mar 17

₹ 0.30

Interim Dividend

2015

Sep 10

₹ 0.31

Rs.3.1000 per share(31%)Dividend

2021

Jun 8

₹ 1

Rs.10.0000 per share(100%)Dividend

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital9999999999
Minority Interest544587911128
113132169193220251271283306352
636990132128248307275222171
Trade Payables78920281830262925
162219281929455875115
Total Liabilities213244299387411562670662653678
103110145143133237259240233411
Capital Work in Progress2132774109801461681770
000002125303443
33405164627585767073
0000000797395
Cash & Bank111341242125151577
4449568286123140555949
Total Assets213244299387411562670662653678

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
42476348722632486564
Cash from Investing-30-26-22-74-38-117-77-23-19-3
Cash from Financing2-11319-1811242-26-52-49
6128-1914-12-1-612

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
53.7353.7353.7353.7353.7353.7353.7353.7353.73
0.520.610.590.870.510.530.520.380.31
DIIs0.000.000.000.000.000.000.000.000.00
Government0.000.000.000.000.000.000.000.000.00
45.7445.6645.6745.3945.7545.7445.7645.8945.95

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-04
General Updates

2026-09-04 - Hester Biosciences Limited has informed the Exchange about Shareholders approval for Reclassification Mr. Ravin Gandhi and Ms. Bela Gandhi from Promoter and Promoter Group category to Public category shareholders of the Company.

2026-09-04
Shareholders meeting

2026-09-04 - Hester Biosciences Limited has informed the Exchange regarding Proceedings of Postal Ballot. Further, the company has informed the Exchange regarding voting results along with copy of scrutinizers report together with copy of minutes.

2026-08-27
Credit Rating

2026-08-27 - Hester Biosciences Limited has informed the Exchange about Credit Rating

2026-08-04
Shareholders meeting

2026-08-04 - Hester Biosciences Limited has informed the Exchange regarding Notice of Postal Ballot

2026-08-01
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-01 - Hester Biosciences Limited has informed the Exchange about Transcript

2026-07-31
General Updates

2026-07-31 - Hester Biosciences Limited has informed the Exchange about General Updates

2026-07-31
Copy of Newspaper Publication

2026-07-31 - Hester Biosciences Limited has informed the Exchange about Copy of Newspaper Publication

2026-07-30
Analysts/Institutional Investor Meet/Con. Call Updates

2026-07-30 - Hester Biosciences Limited has informed the Exchange about Link of Recording

2026-07-30
Press Release

2026-07-30 - Hester Biosciences Limited has informed the Exchange regarding a press release dated July 30, 2026, titled "20260730 Q1 FY27 Press Release".

News

Recent coverage and analyst commentary for HESTERBIO

Loading news…

🤖

AI Stock Analyst

Hester Biosciences Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login